However, an increasing trend has been the clinical applications of hypoimmunogenic, allogeneic iPSC-based cell therapy, attributable to the laborious production and time delay of personalized cells.
← all excerpts
Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies.
1
—
—